Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02143193 · ClinicalTrials.gov registry record · NA
Skin-to Skin Contact on Newborn Temperature
A NA study of Pregnancy and Skin to Skin Contact, sponsored by Rachel Baker.
- Completed
- Registry status
- NA
- Development phase
- 325
- Enrollment target
- 1
- Study location
NCT02143193: Completed NA study of Pregnancy and Skin to Skin Contact, sponsored by Rachel Baker.
NCT02143193 is a NA study of Pregnancy and Skin to Skin Contact that has completed, run by Rachel Baker. The registered enrollment target is 325 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02143193, a NA study of Pregnancy and Skin to Skin Contact, has completed, sponsored by Rachel Baker.
- COMPLETED
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare standard methods of stabilizing a newborn's temperature after birth with mother-infant skin-to-skin contact for stabilizing newborn temperature. The study will look at the effects of each warming method on the timing of newborns' initial bath and the effects on newborn initiation and percent weight loss by discharge. The study will use a randomized controlled trial (RCT) design to test a clinical intervention at TriHealth Good Samaritan Hospital. Study participants will be randomized to the intervention group (IG), which will implement mother-baby Skin-to-Skin (STS) immediately after vaginal birth, or to the control group (CG), which will receive standard care for newborn and mother immediately after vaginal birth. This study will test the hypothesis that mother-baby STS contact implemented immediately after delivery for a minimum of the newborn's first 60 minutes and with a resumption of STS (if a 15-minute break in STS occurs at some point after the first hour) until the newborn's temperature stabilizes after the initial bath will result in: 1. Improved newborn temperature stability and thermoregulation for newborns whether breast or formula-fed. 2. Initiation of effective breastfeeding behavior within 90 minutes of birth and the addition of at least one more breastfeeding within four hours of birth for breastfed newborns. 3. Avoidance of newborn weight loss of 10% or greater.
Conditions Studied
Interventions
- BEHAVIORAL Skin-to-Skin Contact
Study Locations (1)
Ohio
- Good Samaritan TriHealth Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-05 |
| Phase | NA |
What the finished NCT02143193 record still lists
NCT02143193 is an interventional study that assigns participants to a tested intervention. The registered 325 participants enrollment target is mid-sized for trials with a published cap, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (63% lower).
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Skin-to-Skin Contact is the first listed.
NCT02143193 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02143193 about?
NCT02143193 is a clinical study titled "Skin-to Skin Contact on Newborn Temperature". This study will compare standard methods of stabilizing a newborn's temperature after birth with mother-infant skin-to-skin contact for stabilizing newborn temperature. The study will look at the effects of each warming method on the timing of newborns' initial bath and the effects on newborn initia...
What is the current status of trial NCT02143193?
This trial is currently completed. It is a NA study. The enrollment target is 325 participants. The study started on 2011-08. Estimated completion is 2014-05.
What conditions does trial NCT02143193 study?
This clinical trial studies the following conditions: Pregnancy, Skin to Skin Contact.
What interventions are being tested in trial NCT02143193?
The interventions under investigation include: Skin-to-Skin Contact (BEHAVIORAL).
Who is sponsoring clinical trial NCT02143193?
This trial is sponsored by Rachel Baker, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02143193 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02143193's enrollment target sits among peer trials
325 65th of 191 higher than 127 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02543983 · 325 participants · Phase 2
Neurobiology of Suicide
- NCT03016819 · 325 participants · Phase 3
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
- NCT03288207 · 325 participants · NA
Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
- NCT04986657 · 325 participants · NA
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia